Ten years later, the shadow of the case of Dan Markingson still hangs over the University of Minnesota. The details still shock: Markingson, a schizophrenic man, joined a U of M clinical drug trial for the antipsychotic Seroquel. For months during the study, Markingson's mother tried to warn of her son's deteriorating mental state. But it didn't work. The treatment continued, and in May 2004, Markingson stabbed himself to death.
The trial still haunts the school. And yet faculty say the university still isn't serious about taking a serious look into the case. The latest review of the university's program will take place this week, encouraged by the university's faculty senate. The hope was that this might finally be the impartial, independent review that could analyze the Markingson case and put it to bed. But just like in the past, this one's rife with questionable conflicts of interest.More »